BUFOMIX Easyhaler 160mcg/4.5mcg Price

Overview

Welcome to Dwaey, specifically on BUFOMIX Easyhaler 160mcg/4.5mcg Inhalation/Powder For page.
This medicine contains an important and useful components, as it consists of Budesonide, Formoterol fumarate dihydrate.
BUFOMIX Easyhaler 160mcg/4.5mcg is available in the market in concentration 160mcg, 4.5mcg/dose and in the form of Inhalation/Powder For .

HIKMA PHARMACEUTICALS is the producer of BUFOMIX Easyhaler 160mcg/4.5mcg and it is imported from JORDAN, The most popular alternatives of BUFOMIX Easyhaler 160mcg/4.5mcg are listed downward .

Mode Of Action

Budesonide is a corticosteroid that has mainly glucocorticoid activity. It prevents and controls inflammation by controlling the rate of protein syntheis, decreasing the migration of polymorphonuclear leucocytes/fibroblasts and reversing capillary permeability. Formoterol fumarate is a selective beta2-adrenergic agonist. It causes bronchodilation by catalysing the conversion of adenosine triphosphate to cyclic-3', 5'-adenosine monophosphate (cyclic AMP) resulting in bronchial smooth muscle relaxation.

Indication

• Asthma
• COPD

Precaution

Treatment with Budesonide and Formoterol combination should not be initiated to treat a severe exacerbation or if patients have significantly worsening or acutely deteriorating asthma. May produce paradoxical bronchospasm which is life-threatening. Caution when used in patients with CV diseases, especially coronary insufficiency, cardiac arrhythmias and hypertension. Chronic use may further decrease bone mineral content when used in patients with advanced age, osteoporosis, poor nutrition, sedentary lifestyle or tobacco use. May reduce growth velocity when used in paediatric patients. Caution when used in patients with active or quiescent tuberculosis infection of the respiratory tract, untreated systemic fungal, bacterial, viral or parasitic infections, or ocular herpes simplex. Pregnancy and lactation. Lactation: No data; weigh risks of therapy against benefits, and either discontinue drug or do not nurse

Side Effects

• >10% Upper respiratory tract infection (URTI) (8-11%)
• Headache (7-11%)
• Nasopharyngitis (7-11%) 1-10% Pharyngolaryngeal pain (6-9%)
• Stomach discomfort (1-7%)
• Sinusitis (5-6%)
• Oral candidiasis (1-6%)
• Bronchitis (5%)
• Viral URTI (4%)
• Backache (2-3%)
• Influenza (2-3%)
• Nasal congestion (2-3%)
• Vomiting (1- 3%)

Contra indication

Primary treatment of status asthmaticus or other acute episodes of asthma. Hypersensitivity to Budesonide, Formoterol or to Lactose.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks